Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Gastrointestinal therapeutics Market Research Reports

Titlepublishedprice

Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... cross the globe. A key objective of the Acid Indigestion / Heartburn/ Pyrosis Report is to understand the market and pipeline status of the drugs around the Acid Indigestion / Heartburn/ Pyrosis to explore the generic development opportunities, licen......"
01-Sep-2016$2000

Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... jor markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Irritable Bowel Syndrome forecasted market share for ten years to 20......"
01-Sep-2016$4950

Gastric Motility Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... obe. A key objective of the Gastric Motility Disorder Report is to understand the market and pipeline status of the drugs around the Gastric Motility Disorder to explore the generic development opportunities, licensing opportunities and to gain compe......"
01-Sep-2016$2000

Gastritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... tive of the Gastritis Report is to understand the market and pipeline status of the drugs around the Gastritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategie......"
01-Sep-2016$2000

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... e: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Peptic Ulcer forecasted market share for ten years to 2023 segmented by seven majo......"
01-Sep-2016$4950

Helicobacter Pylori Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... he globe. A key objective of the Helicobacter Pylori Infections Report is to understand the market and pipeline status of the drugs around the Helicobacter Pylori Infections to explore the generic development opportunities, licensing opportunities an......"
01-Sep-2016$2000

Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Constipation Report is to understand the market and pipeline status of the drugs around the Constipation to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Duodenal Ulcer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Duodenal Ulcer Report is to understand the market and pipeline status of the drugs around the Duodenal Ulcer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000

Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Gastric Ulcers Report is to understand the market and pipeline status of the drugs around the Gastric Ulcers to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000

Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... be. A key objective of the Irritable Bowel Syndrome Report is to understand the market and pipeline status of the drugs around the Irritable Bowel Syndrome to explore the generic development opportunities, licensing opportunities and to gain competit......"
01-Sep-2016$2000